Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kelly Doran to Streptococcal Infections

This is a "connection" page, showing publications Kelly Doran has written about Streptococcal Infections.

 
Connection Strength
 
 
 
19.437
 
  1. Joyce LR, Brady A, Kim S, Christensen PM, Palmer KL, Guan Z, Siegnethaler JA, Doran KS. Group B streptococcal membrane vesicles induce proinflammatory responses in neonatal meninges. Infect Immun. 2026 Jul 14; 94(7):e0023126.
    View in: PubMed
    Score: 0.807
  2. Keogh RA, Job AM, Joyce LR, Akbari MS, Nguyen A, Kavanaugh JS, Horswill AR, Doran KS. The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus. Infect Immun. 2026 Jul 14; 94(7):e0009926.
    View in: PubMed
    Score: 0.805
  3. Cohen S, Crossen AJ, Jensen O, Neely MN, Le Doare K, Nobbs AH, Ost KS, Doran KS. A fungal pathobiont promotes Streptococcus vaginal persistence and pathogenesis through physical and metabolic interactions. Cell Host Microbe. 2026 Jun 10; 34(6):1118-1134.e7.
    View in: PubMed
    Score: 0.800
  4. Marroquin SM, Cohen S, Neely MN, Doran KS. Akkermansia muciniphila impacts group B Streptococcus vaginal colonization. mBio. 2026 Jun 10; 17(6):e0286825.
    View in: PubMed
    Score: 0.798
  5. Akbari MS, Joyce LR, Spencer BL, Brady A, McIver KS, Doran KS. Identification of glyoxalase A in group B Streptococcus and its contribution to methylglyoxal tolerance and virulence. Infect Immun. 2025 04 08; 93(4):e0054024.
    View in: PubMed
    Score: 0.736
  6. Joyce LR, Kim S, Spencer BL, Christensen PM, Palmer KL, Guan Z, Siegenthaler JA, Doran KS. Streptococcus agalactiae glycolipids promote virulence by thwarting immune cell clearance. Sci Adv. 2024 05 31; 10(22):eadn7848.
    View in: PubMed
    Score: 0.699
  7. Spencer BL, Job AM, Robertson CM, Hameed ZA, Serchejian C, Wiafe-Kwakye CS, Mendonça JC, Apolonio MA, Nagao PE, Neely MN, Korotkova N, Korotkov KV, Patras KA, Doran KS. Heterogeneity of the group B streptococcal type VII secretion system and influence on colonization of the female genital tract. Mol Microbiol. 2023 08; 120(2):258-275.
    View in: PubMed
    Score: 0.656
  8. Akbari MS, Keogh RA, Radin JN, Sanchez-Rosario Y, Johnson MDL, Horswill AR, Kehl-Fie TE, Burcham LR, Doran KS. The impact of nutritional immunity on Group B streptococcal pathogenesis during wound infection. mBio. 2023 08 31; 14(4):e0030423.
    View in: PubMed
    Score: 0.656
  9. Manzer HS, Nguyen DT, Park JY, Park N, Seo KS, Thornton JA, Nobbs AH, Doran KS. The Group B Streptococcal Adhesin BspC Interacts with Host Cytokeratin 19 To Promote Colonization of the Female Reproductive Tract. mBio. 2022 10 26; 13(5):e0178122.
    View in: PubMed
    Score: 0.620
  10. Burcham LR, Burcham ZM, Akbari MS, Metcalf JL, Doran KS. Interrelated Effects of Zinc Deficiency and the Microbiome on Group B Streptococcal Vaginal Colonization. mSphere. 2022 08 31; 7(4):e0026422.
    View in: PubMed
    Score: 0.617
  11. Burcham LR, Akbari MS, Alhajjar N, Keogh RA, Radin JN, Kehl-Fie TE, Belew AT, El-Sayed NM, McIver KS, Doran KS. Genomic Analyses Identify Manganese Homeostasis as a Driver of Group B Streptococcal Vaginal Colonization. mBio. 2022 06 28; 13(3):e0098522.
    View in: PubMed
    Score: 0.609
  12. Burcham LR, Bath JR, Werlang CA, Lyon LM, Liu N, Evans C, Ribbeck K, Doran KS. Role of MUC5B during Group B Streptococcal Vaginal Colonization. mBio. 2022 04 26; 13(2):e0003922.
    View in: PubMed
    Score: 0.601
  13. Manzer HS, Villarreal RI, Doran KS. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. PLoS Pathog. 2022 03; 18(3):e1010397.
    View in: PubMed
    Score: 0.601
  14. Spencer BL, Tak U, Mendonça JC, Nagao PE, Niederweis M, Doran KS. A type VII secretion system in Group B Streptococcus mediates cytotoxicity and virulence. PLoS Pathog. 2021 12; 17(12):e1010121.
    View in: PubMed
    Score: 0.589
  15. Villarreal R, Manzer HS, Keestra-Gounder AM, Doran KS. Vimentin Regulates Chemokine Expression and NOD2 Activation in Brain Endothelium during Group B Streptococcal Infection. Infect Immun. 2021 11 16; 89(12):e0034021.
    View in: PubMed
    Score: 0.579
  16. Burcham LR, Le Breton Y, Radin JN, Spencer BL, Deng L, Hiron A, Ransom MR, Mendonça JDC, Belew AT, El-Sayed NM, McIver KS, Kehl-Fie TE, Doran KS. Identification of Zinc-Dependent Mechanisms Used by Group B Streptococcus To Overcome Calprotectin-Mediated Stress. mBio. 2020 11 10; 11(6).
    View in: PubMed
    Score: 0.547
  17. Burcham LR, Spencer BL, Keeler LR, Runft DL, Patras KA, Neely MN, Doran KS. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS One. 2019; 14(12):e0226699.
    View in: PubMed
    Score: 0.514
  18. Deng L, Spencer BL, Holmes JA, Mu R, Rego S, Weston TA, Hu Y, Sanches GF, Yoon S, Park N, Nagao PE, Jenkinson HF, Thornton JA, Seo KS, Nobbs AH, Doran KS. The Group B Streptococcal surface antigen I/II protein, BspC, interacts with host vimentin to promote adherence to brain endothelium and inflammation during the pathogenesis of meningitis. PLoS Pathog. 2019 06; 15(6):e1007848.
    View in: PubMed
    Score: 0.495
  19. Deng L, Mu R, Weston TA, Spencer BL, Liles RP, Doran KS. Characterization of a Two-Component System Transcriptional Regulator, LtdR, That Impacts Group B Streptococcal Colonization and Disease. Infect Immun. 2018 07; 86(7).
    View in: PubMed
    Score: 0.463
  20. Hancock BM, Doran KS. Importance of strain lineages for Group B streptococcal survival. Virulence. 2017 08 18; 8(6):646-648.
    View in: PubMed
    Score: 0.418
  21. Patras KA, Doran KS. A Murine Model of Group B Streptococcus Vaginal Colonization. J Vis Exp. 2016 11 16; (117).
    View in: PubMed
    Score: 0.415
  22. Mu R, Cutting AS, Del Rosario Y, Villarino N, Stewart L, Weston TA, Patras KA, Doran KS. Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells. PLoS One. 2016; 11(4):e0153891.
    View in: PubMed
    Score: 0.399
  23. Patras KA, Wescombe PA, Rösler B, Hale JD, Tagg JR, Doran KS. Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization. Infect Immun. 2015 Sep; 83(9):3438-44.
    View in: PubMed
    Score: 0.376
  24. Stoner TD, Weston TA, Trejo J, Doran KS. Group B streptococcal infection and activation of human astrocytes. PLoS One. 2015; 10(6):e0128431.
    View in: PubMed
    Score: 0.375
  25. Kim BJ, Hancock BM, Bermudez A, Del Cid N, Reyes E, van Sorge NM, Lauth X, Smurthwaite CA, Hilton BJ, Stotland A, Banerjee A, Buchanan J, Wolkowicz R, Traver D, Doran KS. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest. 2015 Jun; 125(6):2473-83.
    View in: PubMed
    Score: 0.373
  26. Patras KA, Rösler B, Thoman ML, Doran KS. Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus. Mucosal Immunol. 2015 Nov; 8(6):1339-48.
    View in: PubMed
    Score: 0.371
  27. Kim BJ, Hancock BM, Del Cid N, Bermudez A, Traver D, Doran KS. Streptococcus agalactiae infection in zebrafish larvae. Microb Pathog. 2015 Feb; 79:57-60.
    View in: PubMed
    Score: 0.366
  28. Mu R, Kim BJ, Paco C, Del Rosario Y, Courtney HS, Doran KS. Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis. Infect Immun. 2014 Jun; 82(6):2276-86.
    View in: PubMed
    Score: 0.345
  29. Wang NY, Patras KA, Seo HS, Cavaco CK, Rösler B, Neely MN, Sullam PM, Doran KS. Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization. J Infect Dis. 2014 Sep 15; 210(6):982-91.
    View in: PubMed
    Score: 0.344
  30. Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS. A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing. Antimicrob Agents Chemother. 2013 Nov; 57(11):5492-9.
    View in: PubMed
    Score: 0.332
  31. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol. 2011 Dec; 193(24):6834-42.
    View in: PubMed
    Score: 0.291
  32. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis. 2009 May 15; 199(10):1479-87.
    View in: PubMed
    Score: 0.246
  33. Quach D, van Sorge NM, Kristian SA, Bryan JD, Shelver DW, Doran KS. The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J Bacteriol. 2009 Apr; 191(7):2023-32.
    View in: PubMed
    Score: 0.240
  34. Ling J, Joyce LR, Doran KS, Hryckowian AJ. A murine model of adult gastrointestinal colonization by Group B Streptococcus. Infect Immun. 2026 Mar 10; 94(3):e0052725.
    View in: PubMed
    Score: 0.196
  35. Joyce LR, Akbari MS, Nguyen DT, Spencer BL, Rahkola J, McIver KS, Horswill AR, Doran KS, Keogh RA. Global genome analysis identifies glycolipids and lipoteichoic acid alanylation as contributors to group B streptococcal diabetic wound infection. Cell Rep. 2025 Nov 25; 44(11):116510.
    View in: PubMed
    Score: 0.193
  36. Doran KS, Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol. 2004 Oct; 54(1):23-31.
    View in: PubMed
    Score: 0.179
  37. Job AM, Doran KS, Spencer BL. A group B streptococcal type VII-secreted LXG toxin mediates interbacterial competition and colonization of the murine female genital tract. mBio. 2024 10 16; 15(10):e0208824.
    View in: PubMed
    Score: 0.178
  38. Manzer HS, Brunetti T, Doran KS. Identification of a DNA-cytosine methyltransferase that impacts global transcription to promote group B streptococcal vaginal colonization. mBio. 2023 12 19; 14(6):e0230623.
    View in: PubMed
    Score: 0.168
  39. Doran KS, Benoit VM, Gertz RE, Beall B, Nizet V. Late-onset group B streptococcal infection in identical twins: insight to disease pathogenesis. J Perinatol. 2002 Jun; 22(4):326-30.
    View in: PubMed
    Score: 0.152
  40. de Figueiredo Sanches G, Lannes-Costa PS, Cristoforêto MC, Doran KS, Mattos-Guaraldi AL, Nagao PE. Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil. Braz J Microbiol. 2021 Mar; 52(1):303-310.
    View in: PubMed
    Score: 0.138
  41. Lannes-Costa PS, Baraúna RA, Ramos JN, Veras JFC, Conceição MVR, Vieira VV, de Mattos-Guaraldi AL, Ramos RTJ, Doran KS, Silva A, Nagao PE. Comparative genomic analysis and identification of pathogenicity islands of hypervirulent ST-17 Streptococcus agalactiae Brazilian strain. Infect Genet Evol. 2020 06; 80:104195.
    View in: PubMed
    Score: 0.129
  42. Kim BJ, McDonagh MA, Deng L, Gastfriend BD, Schubert-Unkmeir A, Doran KS, Shusta EV. Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells. Fluids Barriers CNS. 2019 Aug 22; 16(1):26.
    View in: PubMed
    Score: 0.126
  43. Vornhagen J, Armistead B, Santana-Ufret V, Gendrin C, Merillat S, Coleman M, Quach P, Boldenow E, Alishetti V, Leonhard-Melief C, Ngo LY, Whidbey C, Doran KS, Curtis C, Waldorf KMA, Nance E, Rajagopal L. Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection. J Clin Invest. 2018 05 01; 128(5):1985-1999.
    View in: PubMed
    Score: 0.114
  44. Gendrin C, Shubin NJ, Boldenow E, Merillat S, Clauson M, Power D, Doran KS, Abrink M, Pejler G, Rajagopal L, Piliponsky AM. Mast cell chymase decreases the severity of group B Streptococcus infections. J Allergy Clin Immunol. 2018 07; 142(1):120-129.e6.
    View in: PubMed
    Score: 0.110
  45. Lazzarin M, Mu R, Fabbrini M, Ghezzo C, Rinaudo CD, Doran KS, Margarit I. Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain. BMC Microbiol. 2017 07 03; 17(1):148.
    View in: PubMed
    Score: 0.108
  46. Gendrin C, Lembo A, Whidbey C, Burnside K, Berry J, Ngo L, Banerjee A, Xue L, Arrington J, Doran KS, Tao WA, Rajagopal L. The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA. Infect Immun. 2015 Mar; 83(3):1078-88.
    View in: PubMed
    Score: 0.091
  47. Patras KA, Wang NY, Fletcher EM, Cavaco CK, Jimenez A, Garg M, Fierer J, Sheen TR, Rajagopal L, Doran KS. Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization. Cell Microbiol. 2013 Jul; 15(7):1154-67.
    View in: PubMed
    Score: 0.080
  48. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog. 2012; 8(10):e1002947.
    View in: PubMed
    Score: 0.078
  49. Lembo A, Gurney MA, Burnside K, Banerjee A, de los Reyes M, Connelly JE, Lin WJ, Jewell KA, Vo A, Renken CW, Doran KS, Rajagopal L. Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol Microbiol. 2010 Jul; 77(2):431-43.
    View in: PubMed
    Score: 0.066
  50. Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med. 2008 Sep 22; 10:e27.
    View in: PubMed
    Score: 0.059
  51. Kaplan A, Chung K, Kocak H, Bertolotto C, Uh A, Hobel CJ, Simmons CF, Doran K, Liu GY, Equils O. Group B streptococcus induces trophoblast death. Microb Pathog. 2008 Sep; 45(3):231-5.
    View in: PubMed
    Score: 0.058
  52. Alves J, Crestani C, Marroquin SM, Johnston ABE, Ring N, Bowen C, Reglinski M, Doran KS, Zadoks RN, Lynskey NN. Acquisition of a novel restriction modification system regulates genetic flux and gene expression in the hypervirulent and globally disseminated CC17 lineage of group B Streptococcus. Nucleic Acids Res. 2026 Jul 03; 54(13).
    View in: PubMed
    Score: 0.051
  53. Keogh RA, Spencer BL, Sorensen HM, Zapf RL, Briaud P, Bonsall AE, Doran KS, Carroll RK. Global Annotation, Expression Analysis, and Stability of Candidate sRNAs in Group B Streptococcus. mBio. 2021 12 21; 12(6):e0280321.
    View in: PubMed
    Score: 0.037
  54. Faralla C, Metruccio MM, De Chiara M, Mu R, Patras KA, Muzzi A, Grandi G, Margarit I, Doran KS, Janulczyk R. Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness. mBio. 2014 May 20; 5(3):e00870-14.
    View in: PubMed
    Score: 0.022
  55. Hensler ME, Quach D, Hsieh CJ, Doran KS, Nizet V. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb Pathog. 2008 Jan; 44(1):84-8.
    View in: PubMed
    Score: 0.014
  56. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, Nizet V. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A. 2004 Oct 05; 101(40):14491-6.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)